ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results.
Saved in:
| Title: | ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results. |
|---|---|
| Authors: | Cox, Timothy M.1, Drelichman, Guillermo I.2, Cravo, Renata3, Balwani, Manisha4, Burrow, Thomas Andrew5, Martins, Ana Maria6, Lukina, Elena7, Rosenbloom, Barry E.8, Ross, Leorah H.9, Angell, Jennifer9, Peterschmitt, M. Judith9 |
| Source: | Molecular Genetics & Metabolism. Feb2015, Vol. 114 Issue 2, pS33-S34. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
